These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 35401058)
1. Pharmaceutical Assessment of Owusu FWA; Boakye-Gyasi ME; Johnson R; Osei YA; Asante E; Bruce Otu DA; Ansong JA; Entsie P; Bayor MT ScientificWorldJournal; 2022; 2022():9810099. PubMed ID: 35401058 [TBL] [Abstract][Full Text] [Related]
2. IDENTIFICATION OF PHARMACEUTICAL EXCIPIENT BEHAVIOR OF CHICKPEA (CICER ARIETINUM) STARCH IN GLICLAZIDE IMMEDIATE RELEASE TABLETS. Meka VS; Yee P; Sheshala R Acta Pol Pharm; 2016; 73(2):469-78. PubMed ID: 27180440 [TBL] [Abstract][Full Text] [Related]
3. Utilization of Pectin from Okra as Binding Agent in Immediate Release Tablets. Owusu FWA; Boakye-Gyasi ME; Entsie P; Bayor MT; Ofori-Kwakye K Biomed Res Int; 2021; 2021():6002286. PubMed ID: 34888384 [TBL] [Abstract][Full Text] [Related]
4. Physicochemical Characterization and Evaluation of the Binding Effect of Desta KH; Tadese E; Molla F Biomed Res Int; 2021; 2021():5571507. PubMed ID: 34692833 [TBL] [Abstract][Full Text] [Related]
5. Physicochemical and Microbiological Characteristics of Stem Bark Exudate Gum of Kipo SL; Ofori-Kwakye K; Kuntworbe N; Johnson R; Boakye-Gyasi ME; Osei YA; Owusu FA ScientificWorldJournal; 2023; 2023():9118067. PubMed ID: 37180374 [TBL] [Abstract][Full Text] [Related]
6. Effect of disintegrants on the properties of multiparticulate tablets comprising starch pellets and excipient granules. Mehta S; De Beer T; Remon JP; Vervaet C Int J Pharm; 2012 Jan; 422(1-2):310-7. PubMed ID: 22101283 [TBL] [Abstract][Full Text] [Related]
7. Biogenic Waste from Two Varieties of Plantain in Ghana Contain Pectin with Potential Binding Properties in Conventional Tablets. Otu DAB; Owusu FWA; Boakye-Gyasi ME; Johnson R; Acquah PGJ; Edzor-Agbo Y; Bayor MT; Archer MA ScientificWorldJournal; 2024; 2024():5461358. PubMed ID: 38915814 [TBL] [Abstract][Full Text] [Related]
8. A New Approach to Enhance the Solubility of Famotidine Tablet by Using Naturally Isolated Pear Starch. Anjali K; Manjul SP Recent Pat Drug Deliv Formul; 2018; 12(1):75-80. PubMed ID: 29303081 [TBL] [Abstract][Full Text] [Related]
9. Potential and Comparative Tablet Disintegrant Properties of Pectin Obtained from Five Okra Genotypes in Ghana. Owusu FWA; Boakye-Gyasi ME; Agbenorhevi JK; Bayor MT; Ofori-Kwakye K Scientifica (Cairo); 2021; 2021():2902335. PubMed ID: 34249381 [TBL] [Abstract][Full Text] [Related]
10. Effects of liquisolid formulations on dissolution of naproxen. Tiong N; Elkordy AA Eur J Pharm Biopharm; 2009 Nov; 73(3):373-84. PubMed ID: 19679184 [TBL] [Abstract][Full Text] [Related]
11. Effect of starch 1500 as a binder and disintegrant in lamivudine tablets prepared by high shear wet granulation. Rahman BM; Ibne-Wahed MI; Khondkar P; Ahmed M; Islam R; Barman RK; Islam MA Pak J Pharm Sci; 2008 Oct; 21(4):455-9. PubMed ID: 18930870 [TBL] [Abstract][Full Text] [Related]
12. Physicochemical Characterization and Evaluation of Yayehrad AT; Marew T; Matsabisa M; Wondie GB Biomed Res Int; 2023; 2023():8852784. PubMed ID: 37593524 [TBL] [Abstract][Full Text] [Related]
13. Impact of chitosan as a disintegrant on the bioavailability of furosemide tablets: in vitro evaluation and in vivo simulation of novel formulations. Rasool BK; Fahmy SA; Galeel OW Pak J Pharm Sci; 2012 Oct; 25(4):815-22. PubMed ID: 23009999 [TBL] [Abstract][Full Text] [Related]
14. Application of general multilevel factorial design with formulation of fast disintegrating tablets containing croscaremellose sodium and Disintequick MCC-25. Solaiman A; Suliman AS; Shinde S; Naz S; Elkordy AA Int J Pharm; 2016 Mar; 501(1-2):87-95. PubMed ID: 26827922 [TBL] [Abstract][Full Text] [Related]
15. Comparison of Disintegrant-addition Methods on the Compounding of Orodispersible Tablets. Mahesparan VA; Bin Abd Razak FS; Ming LC; Uddin AH; Sarker MZI; Bin LK Int J Pharm Compd; 2020; 24(2):148-155. PubMed ID: 32196477 [TBL] [Abstract][Full Text] [Related]
16. Formulation study for orally disintegrating tablet using partly pregelatinized starch binder. Mimura K; Kanada K; Uchida S; Yamada M; Namiki N Chem Pharm Bull (Tokyo); 2011; 59(8):959-64. PubMed ID: 21804239 [TBL] [Abstract][Full Text] [Related]
17. Comparative studies of binding potential of Prunus armeniaca and Prunus domestica gums in tablets formulations. Rahim H; Khan MA; Sadiq A; Khan S; Chishti KA; Rahman IU Pak J Pharm Sci; 2015 May; 28(3):909-14. PubMed ID: 26004724 [TBL] [Abstract][Full Text] [Related]
18. Factors affecting the disintegration and dissolution of chloroquine phosphate/starch tablets. Pilpel N; Otuyemi SO; Kurup TR J Pharm Pharmacol; 1978 Apr; 30(4):214-9. PubMed ID: 24707 [TBL] [Abstract][Full Text] [Related]
19. Effect of different excipients on the physical characteristics of granules and tablets with carbamazepine prepared with polyethylene glycol 6000 by fluidized hot-melt granulation (FHMG). Kraciuk R; Sznitowska M AAPS PharmSciTech; 2011 Dec; 12(4):1241-7. PubMed ID: 21948307 [TBL] [Abstract][Full Text] [Related]
20. Investigation of Abbas S; Sherazi M; Khan A; Alyami HS; Latif M; Qureshi ZU; Majeedullah ; Asad MHHB Biomed Res Int; 2021; 2021():5538075. PubMed ID: 34235217 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]